10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionPathstone Holdings, LLC
Latest Disclosed Ownership25,296 shares
Latest Disclosed Value $ 537,034
Pathstone Holdings, LLC reports 0.55% decrease in ownership of TXG / 10x Genomics, Inc.

On May 11, 2026 - Pathstone Holdings, LLC filed a 13F-HR form disclosing ownership of 25,296 shares of 10x Genomics, Inc. (MX:TXG) valued at $537,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 25,436 shares of 10x Genomics, Inc.. This represents a change in shares of -0.55% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 25,296 -140 -0.55 537 29.71 0.0012
2026-02-13 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 25,436 -15,221 -37.44 415 -12.84 0.0016
2025-11-13 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 40,657 -576 -1.40 475 -0.42 0.0018
2025-08-12 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 41,233 -2,417 -5.54 477 25.20 0.0019
2025-05-15 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 43,650 7,051 19.27 382 -27.43 0.0017
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 36,599 13,385 57.66 526 0.19 0.0023
2024-11-07 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 23,214 743 3.31 524 19.91 0.0023
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 22,471 -125 -0.55 437 -48.47 0.0020
2024-05-13 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 22,596 472 2.13 848 -31.50 0.0040
2024-02-14 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 22,124 22,124 1,238 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.